View Webinar (Jointly provided by SNMMI, July 2019)*
Speakers: Daniel Pryma, MD, University of Pennsylvania; and Amanda Abbott, MS, CNMT, RT(N)(CT), PET, Dana-Farber Cancer Institute
Learning Objectives:
- Understand the regulatory considerations for the administration of 177Lu-DOTATATE
- Appreciate the logistical considerations and space planning for treatment
- Understand the adjunctive medication options and their appropriate utilization
Credit type/Info: AMA, SAM, VOICE